![]() |
Manufacturers’ quality issues were among the most prevalent reasons for drug shortages, according to a new industry survey. Related news |
The US Supreme Court has ruled unanimously that naturally occurring DNA is not patentable “merely because it has been isolated,” but synthetic DNA can be patented.
The latest technology platform from Capsugel's four-month old DFS Unit offers greater bioavailabilty and stability in oral dose formulation, says the company.
ATMI has opened a development and testing lab in the US to let customers test its single-use production and technologies.
A US CMO that promised to make cost-effective, generic insulin has been sued by the city where it planned to set up a manufacturing plant.
Logistics company DHL has launched a new temperature controlled air freight service to service for biologics.
Demand is at an all time high according to CRO Chiltern, which reported that its revenue grew more than 16% from the last fiscal year.
Calvert Labs and EyeCRO have teamed up, citing growing demand for integrated early-phase services for ocular drugs.
Canadian CMO Patheon’s second quarter revenues increased almost 40 percent as the company’s commercial manufacturing services revenues saw a similarly high rise over the same period from last year.
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference